BioSpace News Archive

Brad Perkins, M.D., newly appointed CMO of Karius, has had his eyes on grand scientific achievements since childhood.

The medical regulator’s green light is a milestone in the global fight against specific types of late-stage blood cancer, as CAR T-cell therapy has been found to be effective against them.

There’s plenty of money on the move as venture capital firms and investors look to the future of biotech. Read on for today’s top Series A rounds.

As BioSpace releases its third annual 2021 U.S. Life Sciences Salary Report, there are hopeful surprises and unsettling truths.

Concerns over vaccination links to heart inflammation are valid, a U.S. Centers for Disease Control and Prevention advisory committee announced this afternoon.

Just like first impressions, the first 30 days at your new job can set the tone for a new position.

Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group, further accelerated its path toward becoming a fully sustainable company, despite an extremely challenging 2020, which was overshadowed by the COVID-19 pandemic.

RapidPulse, Inc. today announced the closing of a $15 million Series A financing.

Medtronic plc today announced its participation at the American Diabetes Association (ADA) 81th scientific sessions virtual meeting, June 25-29, 2021.

Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing proprietary novel immuno-oncology therapies to activate the immune system against cancer, announced today that the first patient was treated in a First-in-Human Phase 1 clinical trial evaluating BDB018 in advanced solid tumors.